Safello Group AB Publishes Annual Report for 2021

Stockholm, 29 March 2022 | Today, Safello Group AB ("Safello") publishes the company's annual report for 2021. The annual report is available in Swedish, with an English translation, on the company's website: Safello Financial Reports (https://safello.com/investors/reports/).

"The past year has flown by and was one of monumental change for both Safello and the market. Apart from delivering on our promises in the prospectus, we took the market leadership position in Sweden and started the new year by signing an LOI with Avanza to kick off our Crypto-as-a-Service strategy. Cryptocurrency user adoption is now on track with the Internet some 20 years ago. The team and I are very excited to see how fast the landscape evolves and how we can work with institutions embracing this future," says Frank Schuil, CEO and co-founder of Safello. 

For environmental and cost reasons, Safello Group AB has decided not to print the report. A printout may be distributed to shareholders upon request.


This information is such that Safello Group AB is required to disclose in accordance with the Swedish Securities Markets Act. The information was provided by the contact person below, for publication on 29 March 2022.

For more information, please contact
Johan Edin, CFO, ir@safello.com

Certified Adviser
Corpura Fondkommission AB, info@corpura.se,+46 722 52 34 51

Safello is Sweden's leading online cryptocurrency brokerage with the goal to make crypto accessible to everyone. Safello offers a secure way to buy, sell and store crypto in seamless transactions at industry-leading speeds. Operating in Sweden, Safello has been registered as a financial institution with Finansinspektionen (Swedish Financial Supervisory Authority) since 2013 and is listed at Nasdaq First North Growth Market since 2021.

Source: Cision

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.